Market Cap 8.47M
Revenue (ttm) 9.36M
Net Income (ttm) -9.04M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -96.58%
Debt to Equity Ratio 0.10
Volume 1,193,400
Avg Vol 15,480,302
Day's Range N/A - N/A
Shares Out 27.96M
Stochastic %K 17%
Beta 2.54
Analysts Hold
Price Target $6.00

Latest News on BIAF

bioAffinity Technologies Reports First Quarter 2025 Results

May 15, 2025, 8:30 AM EDT - 21 days ago

bioAffinity Technologies Reports First Quarter 2025 Results


bioAffinity Technologies Set for Continued Expansion in 2025

Dec 12, 2024, 8:00 AM EST - 6 months ago

bioAffinity Technologies Set for Continued Expansion in 2025


bioAffinity Technologies News Update

May 2, 2024, 8:00 AM EDT - 1 year ago

bioAffinity Technologies News Update